Podcast – Responding to Industry Trends for Auto Injectors and Pen Injectors
In this podcast, Executive Director of Business Development in Europe, Nick Heaton, talks about the major drivers of growing demands in Europe for advanced drug delivery devices, and the measures taken to enhance our relationship with patients and biopharmaceutical companies. Heaton also addresses challenges faced when launching a new product and explains the main difference between preconfigured program and development program offered by SHL, as well each program’s respective opportunities and advantages.
To subscribe to the SHL Podcast Feed, please click HERE.
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices such as auto injectors and pen injectors. We have over 3,000 staff globally, with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of several distinct group companies:
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
Develops and manufactures equipment solutions for home, hospital and long term care use
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
Provides final assembly, labeling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries
For additional information visit www.shl-group.com or contact us at firstname.lastname@example.org
SHL Media Contact